Study Reveals Pharmaceutical Product-Liability Plaintiffs Drawn to Sue in California
Topic: Judiciary and Courts
By Mark A. Behrens, a Partner with Shook, Hardy & Bacon LLP in the firm’s Washington, DC office, who also serves as a member of WLF’s Legal Policy Advisory Board.
Legal Opinion Letter, January 2017, 2 pages
Download a PDF of the Publication
A non-profit organization’s study confirms that California remains an attractive venue for out-of-state plaintiffs who sue pharmaceutical companies, thanks to a number of factors, including permissive tort-liability rules, state-court rulings on personal jurisdiction, and the absence of a statutory-damages cap.